| COVID-19 Vaccine |
1 |
1 |
| Monoclonal Antibody |
0 |
0.99 |
| Antineoplastic Drug |
0 |
0.86 |
| Biologic Therapy |
0 |
0.82 |
| COVID-19 |
0 |
0.61 |
| Vaccines |
0 |
0.58 |
| Immunization |
0 |
0.34 |
| T-Lymphocyte |
0 |
0.32 |
| Hospital |
0 |
0.2 |
| Severe Acute Respiratory Syndrome |
0 |
0.13 |
| Surgery |
0 |
0.09 |
| Acute Respiratory Distress Syndrome |
0 |
0.07 |
| Arthritis |
0 |
0.07 |
| Autoimmune Disease |
0 |
0.07 |
| Vasculitis |
0 |
0.06 |
| Scleroderma |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.04 |
| Lymphocytes |
0 |
0.04 |
| Rheumatic Disease |
0 |
0.04 |
| Rheumatoid Arthritis |
0 |
0.04 |
| Cancer |
0 |
0.02 |
| CD4 |
0 |
0.02 |
| Food and Drug Administration (FDA) |
0 |
0.02 |
| Myositis |
0 |
0.02 |
| New York |
0 |
0.02 |
| Pandemic |
0 |
0.02 |
| Receptors |
0 |
0.02 |
| Remission |
0 |
0.02 |
| Mechanical Ventilation |
0 |
0.01 |